Gene cloning and overproduction of low-specificity D-threonine aldolase from Alcaligenes xylosoxidans and its application for production of a key intermediate for parkinsonism drug

Citation
Jq. Liu et al., Gene cloning and overproduction of low-specificity D-threonine aldolase from Alcaligenes xylosoxidans and its application for production of a key intermediate for parkinsonism drug, APPL MICR B, 54(1), 2000, pp. 44-51
Citations number
20
Categorie Soggetti
Biotecnology & Applied Microbiology",Microbiology
Journal title
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
ISSN journal
01757598 → ACNP
Volume
54
Issue
1
Year of publication
2000
Pages
44 - 51
Database
ISI
SICI code
0175-7598(200007)54:1<44:GCAOOL>2.0.ZU;2-7
Abstract
The dtaAX gene encoding a pyridoxal 5'-phosphate (pyridoxal-P)-dependent lo w-specificity D-threonine aldolase was cloned from the chromosomal DNA of A lcaligenes xylosoxidans IFO 12669. It contains an open reading frame consis ting of 1,134 nucleotides corresponding to 377 amino acid residues. The pre dicted amino acid sequence displayed 54% identity with that of D-threonine aldolase from gram-positive bacteria Ar-throbacter sp. DK-38, but showed no significant similarity with those of other known pyridoxal-P enzymes. This gram-negative bacterial enzyme was highly overproduced in recombinant Esch erickia coli cells, and the specific activity of the enzyme in the cell ext ract was as high as 18 U/mg (purified enzyme 38.6 U/mg), which was 6,000 ti mes higher than that from the wild-type Alcaligenes cell extract. The recom binant enzyme was thus feasibly purified to homogeneity by ammonium sulfate fractionation and DEAE-Toyopearl chromatography steps. The recombinant low -specificity D-threonine aldolase was shown to be an efficient biocatalyst for resolution of L-beta-3,4-methylenedioxyphenylserine, an intermediate fo r production of a therapeutic drug for Parkinson's disease.